{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T22:57:37Z","timestamp":1792364257137,"version":"4.4.0"},"reference-count":207,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,3,18]],"date-time":"2019-03-18T00:00:00Z","timestamp":1552867200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Bone Oncology"],"published-print":{"date-parts":[[2019,6]]},"DOI":"10.1016\/j.jbo.2019.100231","type":"journal-article","created":{"date-parts":[[2019,3,19]],"date-time":"2019-03-19T11:10:28Z","timestamp":1552993828000},"page":"100231","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":33,"special_numbering":"C","title":["Mesenchymal stromal cells for bone sarcoma treatment: Roadmap to clinical practice"],"prefix":"10.1016","volume":"16","author":[{"given":"Alexandros","family":"Stamatopoulos","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theodosios","family":"Stamatopoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zakareya","family":"Gamie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eustathios","family":"Kenanidis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ricardo Da Conceicao","family":"Ribeiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth Samora","family":"Rankin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Craig","family":"Gerrand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth","family":"Dalgarno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eleftherios","family":"Tsiridis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jbo.2019.100231_bib0001","doi-asserted-by":"crossref","DOI":"10.1016\/j.suc.2016.05.005","article-title":"Epidemiology and etiology of sarcomas","author":"Hui","year":"2016","journal-title":"Surg. Clin. North Am"},{"key":"10.1016\/j.jbo.2019.100231_bib0002","article-title":"Epidemiology and therapies for metastatic sarcoma","author":"Amankwah","year":"2013","journal-title":"Clin. Epidemiol"},{"key":"10.1016\/j.jbo.2019.100231_bib0003","series-title":"Cancer Treatment and Research","article-title":"Pediatric and adolescent osteosarcoma","author":"Ottaviani","year":"2009"},{"key":"10.1016\/j.jbo.2019.100231_bib0004","doi-asserted-by":"crossref","DOI":"10.1200\/EDBK_175378","article-title":"Advances in the treatment of pediatric bone sarcomas","author":"Grohar","year":"2017","journal-title":"Am. Soc. Clin. Oncol. Educ. B"},{"key":"10.1016\/j.jbo.2019.100231_bib0005","doi-asserted-by":"crossref","first-page":"465","DOI":"10.3109\/10799893.2015.1122045","article-title":"JNK pathway in osteosarcoma: pathogenesis and therapeutics, J","volume":"36","author":"Li","year":"2016","journal-title":"Recept. Signal Transduct."},{"key":"10.1016\/j.jbo.2019.100231_bib0006","doi-asserted-by":"crossref","first-page":"637","DOI":"10.2217\/fon-2016-0226","article-title":"Novel therapeutic approaches in chondrosarcoma","volume":"13","author":"Polychronidou","year":"2017","journal-title":"Futur. Oncol"},{"key":"10.1016\/j.jbo.2019.100231_bib0007","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.clon.2012.07.010","article-title":"Management of bone tumours in paediatric oncology","volume":"25","author":"B\u00f6lling","year":"2013","journal-title":"Clin. Oncol"},{"key":"10.1016\/j.jbo.2019.100231_bib0008","first-page":"6","article-title":"UK guidelines for the management of bone sarcomas","author":"Gerrand","year":"2016","journal-title":"Clin Sarcoma Res"},{"key":"10.1016\/j.jbo.2019.100231_bib0009","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S0092-8674(00)81692-X","article-title":"Stem cells: units of development, units of regeneration, and units in evolution","volume":"100","author":"Weissman","year":"2000","journal-title":"Cell"},{"key":"10.1016\/j.jbo.2019.100231_bib0010","first-page":"831","article-title":"Application of adult mesenchymal stem cells in bone and vascular tissue engineering","volume":"67","author":"Tr\u00e1vn\u00ed\u010dkov\u00e1","year":"2018","journal-title":"Physiol. Res."},{"key":"10.1016\/j.jbo.2019.100231_bib0011","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2017.10.127","article-title":"Cytotherapy using stromal cells: current and advance multi-treatment approaches","author":"Shende","year":"2018","journal-title":"Biomed. Pharmacother"},{"key":"10.1016\/j.jbo.2019.100231_bib0012","doi-asserted-by":"crossref","DOI":"10.1111\/nyas.13553","article-title":"Designing the stem cell microenvironment for guided connective tissue regeneration","author":"Bogdanowicz","year":"2017","journal-title":"Ann. N. Y. Acad. Sci"},{"key":"10.1016\/j.jbo.2019.100231_bib0013","first-page":"41","article-title":"Potential of mesenchymal stem cell based application in cancer","volume":"9","author":"Ramdasi","year":"2015","journal-title":"Int. J. Hematol. Stem Cell Res"},{"key":"10.1016\/j.jbo.2019.100231_bib0014","doi-asserted-by":"crossref","DOI":"10.1016\/j.medcli.2016.11.033","article-title":"Caracter\u00edsticas, aplicaciones y perspectivas de las c\u00e9lulas madre mesenquimales en terapia celular","author":"Guadix","year":"2017","journal-title":"Med. Clin. (Barc)"},{"key":"10.1016\/j.jbo.2019.100231_bib0015","doi-asserted-by":"crossref","first-page":"1880","DOI":"10.1126\/science.1110542","article-title":"Stem Cells and Their Niches","volume":"311","author":"Moore","year":"2006","journal-title":"Science (80-.)"},{"key":"10.1016\/j.jbo.2019.100231_bib0016","doi-asserted-by":"crossref","DOI":"10.1242\/dev.165399","article-title":"Signaling in the stem cell niche: regulating cell fate, function and plasticity","author":"Chac\u00f3n-Mart\u00ednez","year":"2018","journal-title":"Development"},{"key":"10.1016\/j.jbo.2019.100231_bib0017","doi-asserted-by":"crossref","first-page":"3377","DOI":"10.1016\/j.yexcr.2007.07.027","article-title":"Stem cell niches in mammals","volume":"313","author":"Mitsiadis","year":"2007","journal-title":"Exp. Cell Res"},{"key":"10.1016\/j.jbo.2019.100231_bib0018","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.2741\/e509","article-title":"Tumor-stroma interactions in tumorigenesis: lessons from stem cell biology","author":"Briest","year":"2012","journal-title":"Front. Biosci"},{"key":"10.1016\/j.jbo.2019.100231_bib0019","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1056\/NEJM198612253152606","article-title":"Tumors: wounds that do not heal","volume":"315","author":"Dvorak","year":"1986","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jbo.2019.100231_bib0020","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1038\/gt.2008.39","article-title":"Inflammation and tumor microenvironments: defining the migratory itinerary of mesenchymal stem cells","volume":"15","author":"Spaeth","year":"2008","journal-title":"Gene Ther."},{"key":"10.1016\/j.jbo.2019.100231_bib0021","first-page":"1","article-title":"Mesenchymal stem cells and cancer: friends or enemies?","author":"Hong","year":"2014","journal-title":"Mutat. Res. - Fundam. Mol. Mech. Mutagen"},{"key":"10.1016\/j.jbo.2019.100231_bib0022","doi-asserted-by":"crossref","first-page":"2235","DOI":"10.1016\/j.biochi.2013.05.010","article-title":"Mesenchymal stem cell secretome and regenerative therapy after cancer","volume":"95","author":"Zimmerlin","year":"2013","journal-title":"Biochimie"},{"key":"10.1016\/j.jbo.2019.100231_bib0023","doi-asserted-by":"crossref","unstructured":"I. Christodoulou, M. Goulielmaki, M. Devetzi, M. Panagiotidis, G. Koliakos, Mesenchymal stem cells in preclinical cancer cytotherapy\u202f: a systematic review, 8 (2018) 1\u201338.","DOI":"10.1186\/s13287-018-1078-8"},{"key":"10.1016\/j.jbo.2019.100231_bib0024","doi-asserted-by":"crossref","DOI":"10.1002\/jnr.21983","article-title":"Role of monocyte chemoattractant protein-1 (MCP-1\/CCL2) in migration of neural progenitor cells toward glial tumors","author":"Magge","year":"2009","journal-title":"J. Neurosci. Res"},{"key":"10.1016\/j.jbo.2019.100231_bib0025","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1172\/JCI200420001","article-title":"Neuronally expressed stem cell factor induces neural stem cell migration to areas of brain injury","volume":"113","author":"Sun","year":"2004","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.jbo.2019.100231_bib0026","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1634\/stemcells.2005-0271","article-title":"Migration of bone marrow and cord blood mesenchymal stem cells in vitro is regulated by stromal-derived factor-1-CXCR4 and hepatocyte growth factor-c-met axes and involves matrix metalloproteinases","volume":"24","author":"Son","year":"2006","journal-title":"Stem Cells"},{"key":"10.1016\/j.jbo.2019.100231_bib0027","doi-asserted-by":"crossref","first-page":"18117","DOI":"10.1073\/pnas.0408258102","article-title":"Directed migration of neural stem cells to sites of CNS injury by the stromal cell-derived factor 1alpha\/CXC chemokine receptor 4 pathway","volume":"101","author":"Imitola","year":"2004","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.jbo.2019.100231_bib0028","doi-asserted-by":"crossref","first-page":"5901","DOI":"10.1523\/JNEUROSCI.1083-08.2008","article-title":"Hepatocyte growth factor regulates migration of olfactory interneuron precursors in the rostral migratory stream through Met-Grb2 coupling","volume":"28","author":"Garzotto","year":"2008","journal-title":"J. Neurosci"},{"key":"10.1016\/j.jbo.2019.100231_bib0029","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1593\/neo.04781","article-title":"Brain tumor tropism of transplanted human neural stem cells is induced by vascular endothelial growth factor","volume":"7","author":"Schmidt","year":"2005","journal-title":"Neoplasia"},{"key":"10.1016\/j.jbo.2019.100231_bib0030","doi-asserted-by":"crossref","first-page":"11068","DOI":"10.1073\/pnas.1006375107","article-title":"Migration of engrafted neural stem cells is mediated by CXCL12 signaling through CXCR4 in a viral model of multiple sclerosis","volume":"107","author":"Carbajal","year":"2010","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.jbo.2019.100231_bib0031","first-page":"290","article-title":"Recent discoveries concerning the tumor \u2013 mesenchymal stem cell interactions","volume":"1866","author":"Lazennec","year":"2016","journal-title":"Biochim. Biophys. Acta."},{"key":"10.1016\/j.jbo.2019.100231_bib0032","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.canlet.2011.02.012","article-title":"Potential implications of mesenchymal stem cells in cancer therapy","volume":"305","author":"Dai","year":"2011","journal-title":"Cancer Lett"},{"key":"10.1016\/j.jbo.2019.100231_bib0033","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1007\/978-1-59745-536-7_16","article-title":"Immune properties of mesenchymal stem cells","volume":"407","author":"Sotiropoulou","year":"2007","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.jbo.2019.100231_bib0034","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1038\/cr.2010.44","article-title":"Mesenchymal stem cells: a new strategy for immunosuppression and tissue repair","volume":"20","author":"Shi","year":"2010","journal-title":"Cell Res."},{"key":"10.1016\/j.jbo.2019.100231_bib0035","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.stem.2007.11.014","article-title":"Mesenchymal stem cell-mediated immunosuppression occurs via concerted action of chemokines and nitric oxide","volume":"2","author":"Ren","year":"2008","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.jbo.2019.100231_bib0036","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/scrt2","article-title":"Immunosuppression by mesenchymal stem cells: mechanisms and clinical applications","volume":"1","author":"Ghannam","year":"2010","journal-title":"Stem Cell Res. Ther"},{"key":"10.1016\/j.jbo.2019.100231_bib0037","first-page":"367","article-title":"Human mesenchymal stem cells modulate B-cell functions","volume":"107","author":"Corcione","year":"2006","journal-title":"Mult. Scler."},{"key":"10.1016\/j.jbo.2019.100231_bib0038","doi-asserted-by":"crossref","unstructured":"M. Di Nicola, C. Carlo-stella, M. Magni, M. Milanesi, P.D. Longoni, S. Grisanti, A.M. Gianni, M. Di Nicola, C. Carlo-stella, M. Magni, M. Milanesi, P.D. Longoni, P. Matteucci, S. Grisanti, A.M. Gianni, induced by cellular or nonspecific mitogenic stimuli Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli, 99 (2013) 3838\u20133843. doi:10.1182\/blood.V99.10.3838.","DOI":"10.1182\/blood.V99.10.3838"},{"key":"10.1016\/j.jbo.2019.100231_bib0039","first-page":"1597","article-title":"Mesenchymal stem cells induce apoptosis of activated T cells","volume":"19","author":"Plumas","year":"2005","journal-title":"Leuk. Off. J. Leuk. Soc. Am. Leuk. Res. Fund, U.K"},{"key":"10.1016\/j.jbo.2019.100231_bib0040","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1182\/blood-2006-03-006403","article-title":"Tolerogenic dendritic cells\u202f: cytokine modulation comes of age","volume":"108","author":"Rutella","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.jbo.2019.100231_bib0041","doi-asserted-by":"crossref","first-page":"881","DOI":"10.3324\/haematol.11240","article-title":"Generation of CD4+ or CD8+ regulatory T cells upon mesenchymal stem cell-lymphocyte interaction","volume":"92","author":"Prevosto","year":"2007","journal-title":"Haematologica"},{"key":"10.1016\/j.jbo.2019.100231_bib0042","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1634\/stemcells.2005-0319","article-title":"Human bone marrow stromal cells express a distinct set of biologically functional chemokine receptors","volume":"24","author":"Honczarenko","year":"2006","journal-title":"Stem Cells"},{"key":"10.1016\/j.jbo.2019.100231_bib0043","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1161\/01.RES.0000118601.37875.AC","article-title":"Marrow-derived stromal cells express genes encoding a broad spectrum of arteriogenic cytokines and promote in vitro and in vivo arteriogenesis through paracrine mechanisms","volume":"94","author":"Kinnaird","year":"2004","journal-title":"Circ. Res"},{"key":"10.1016\/j.jbo.2019.100231_bib0044","first-page":"717","article-title":"Review of mesenchymal stem cells and tumors: executioner or coconspirator?","volume":"24","author":"Feng","year":"2009","journal-title":"Cancer Biother. Radiopharm"},{"key":"10.1016\/j.jbo.2019.100231_bib0045","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1038\/sj.bjc.6604508","article-title":"VEGF expression by mesenchymal stem cells contributes to angiogenesis in pancreatic carcinoma","volume":"99","author":"Beckermann","year":"2008","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.jbo.2019.100231_bib0046","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1038\/ncponc1089","article-title":"Mechanisms of disease: epithelial-mesenchymal transition - does cellular plasticity fuel neoplastic progression?","volume":"5","author":"Turley","year":"2008","journal-title":"Nat. Clin. Pract. Oncol"},{"key":"10.1016\/j.jbo.2019.100231_bib0047","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1111\/j.1349-7006.2009.01419.x","article-title":"Epithelial-mesenchymal transition in cancer development and its clinical significance","volume":"101","author":"Iwatsuki","year":"2010","journal-title":"Cancer Sci."},{"key":"10.1016\/j.jbo.2019.100231_bib0048","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1007\/s10549-010-0734-1","article-title":"Potential role of mesenchymal stem cells (MSCs) in the breast tumour microenvironment\u202f: stimulation of epithelial to mesenchymal transition (EMT)","volume":"124","author":"Martin","year":"2010","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.jbo.2019.100231_bib0049","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1182\/blood-2003-03-0802","article-title":"PML-RAR \u03b1 is associated with leptin-receptor induction\u202f: the role of mesenchymal stem cell \u2013 derived adipocytes in APL cell survival","volume":"103","author":"Tabe","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.jbo.2019.100231_bib0050","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1080\/14653240902807026","article-title":"Therapeutic potential of mesenchymal stromal cells in a mouse breast cancer metastasis model","volume":"11","author":"Sun","year":"2009","journal-title":"Cytotherapy"},{"key":"10.1016\/j.jbo.2019.100231_bib0051","doi-asserted-by":"crossref","first-page":"1674","DOI":"10.1111\/j.1471-4159.2009.06268.x","article-title":"Neuroprotective mesenchymal stem cells are endowed with a potent antioxidant effect in vivo","volume":"110","author":"Lanza","year":"2009","journal-title":"J. Neurochem"},{"key":"10.1016\/j.jbo.2019.100231_bib0052","doi-asserted-by":"crossref","first-page":"245","DOI":"10.4161\/cbt.7.2.5296","article-title":"The growth inhibitory effect of mesenchymal stem cells on tumor cells in vitro and in vivo","volume":"7","author":"Lu","year":"2016","journal-title":"Cancer Biol. Ther"},{"key":"10.1016\/j.jbo.2019.100231_bib0053","doi-asserted-by":"crossref","DOI":"10.1007\/s13277-016-5187-7","article-title":"Mesenchymal stem cells as a double-edged sword in suppression or progression of solid tumor cells","author":"Norozi","year":"2016","journal-title":"Tumor Biol"},{"key":"10.1016\/j.jbo.2019.100231_bib0054","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1038\/35102167","article-title":"Stem cells, cancer, and cancer stem cells","volume":"414","author":"Tannishtha","year":"2001","journal-title":"Nature"},{"key":"10.1016\/j.jbo.2019.100231_bib0055","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1136\/thx.2009.128025","article-title":"Stem cells as vectors for antitumour therapy","volume":"65","author":"Loebinger","year":"2010","journal-title":"Thorax"},{"key":"10.1016\/j.jbo.2019.100231_bib0056","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1038\/nrg1427","article-title":"WNT and beta-catenin signalling: diseases and therapies","volume":"5","author":"Moon","year":"2004","journal-title":"Nat. Rev. Genet"},{"key":"10.1016\/j.jbo.2019.100231_bib0057","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1002\/cncr.20518","article-title":"Up-regulation of Wnt-1 and beta-catenin production in patients with advanced metastatic prostate carcinoma: potential pathogenetic and prognostic implications","volume":"101","author":"Chen","year":"2004","journal-title":"Cancer"},{"key":"10.1016\/j.jbo.2019.100231_bib0058","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1007\/s11010-013-1836-y","article-title":"Human umbilical cord mesenchymal stem cells inhibit C6 glioma growth via secretion of dickkopf-1 (DKK1)","volume":"1","author":"Ma","year":"2014","journal-title":"Mol Cell Biochem"},{"key":"10.1016\/j.jbo.2019.100231_bib0059","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1084\/jem.20051921","article-title":"Human mesenchymal stem cells exert potent antitumorigenic effects in a model of Kaposi\u2019s sarcoma","volume":"203","author":"Khakoo","year":"2006","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.jbo.2019.100231_bib0060","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.ctrv.2012.03.005","article-title":"Mesenchymal stem cell signaling in cancer progression","volume":"39","author":"Torsvik","year":"2013","journal-title":"Cancer Treat. Rev"},{"key":"10.1016\/j.jbo.2019.100231_bib0061","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1084\/jem.20051921","article-title":"Human mesenchymal stem cells exert potent antitumorigenic effects in a model of Kaposi \u2019 s sarcoma","volume":"203","author":"Khakoo","year":"2006","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.jbo.2019.100231_bib0062","first-page":"5","article-title":"Upregulation of PTEN in glioma cells by cord blood mesenchymal stem cells inhibits migration via downregulation of the PI3K \/ Akt Pathway","author":"Dasari","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.jbo.2019.100231_bib0063","first-page":"438","article-title":"Stem cells and breast cancer, where we are? A concise review of literature","volume":"32","author":"Sanguinetti","year":"2011","journal-title":"G. Chir."},{"key":"10.1016\/j.jbo.2019.100231_bib0064","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/scrt443","article-title":"Umbilical cord tissue-derived mesenchymal stem cells induce apoptosis in PC-3 prostate cancer cells through activation of JNK and downregulation of PI3K \/ AKT signaling","volume":"5","author":"Han","year":"2014","journal-title":"Stem Cell Res. Ther"},{"key":"10.1016\/j.jbo.2019.100231_bib0065","first-page":"1","article-title":"Paracrine factors of human fetal mscs inhibit liver cancer growth through reduced activation of IGF-1R \/ PI3K \/ Akt Signaling","author":"Yulyana","year":"2014","journal-title":"Am. Soc. Gene Cell Ther"},{"key":"10.1016\/j.jbo.2019.100231_bib0066","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1016\/j.stem.2011.05.012","article-title":"Perspective assessing the safety of stem cell therapeutics diagnosis of stem cell","volume":"8","author":"Goldring","year":"2011","journal-title":"Cell. Stem. Cell."},{"key":"10.1016\/j.jbo.2019.100231_bib0067","doi-asserted-by":"crossref","unstructured":"F. Djouad, P. Plence, C. Bony, P. Tropel, F. Apparailly, J. Sany, Immunosuppressive effect of mesenchymal stem cells favors tumor growth in allogeneic animals, 102 (2003) 3837\u20133845. doi:10.1182\/blood-2003-04-1193.D.N.","DOI":"10.1182\/blood-2003-04-1193"},{"key":"10.1016\/j.jbo.2019.100231_bib0068","doi-asserted-by":"crossref","unstructured":"F. Djouad, C. Bony, D. Noel, Earlier onset of syngeneic tumors in the presence of transplantation. (2006) 1060\u20131066. doi:10.1097\/01.tp.0000236098.13804.0b.","DOI":"10.1097\/01.tp.0000236098.13804.0b"},{"key":"10.1016\/j.jbo.2019.100231_bib0069","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.yexmp.2005.07.004","article-title":"Mesenchymal stem cells derived from bone marrow favor tumor cell growth in vivo","volume":"80","author":"Zhu","year":"2006","journal-title":"Exp. Mol. Pathol"},{"key":"10.1016\/j.jbo.2019.100231_bib0070","doi-asserted-by":"crossref","first-page":"3763","DOI":"10.1096\/fj.07-8832com","article-title":"Interleukin-6 is a potent growth factor for ER-\u03b1-positive human breast cancer","volume":"21","author":"Sasser","year":"2007","journal-title":"FASEB J"},{"key":"10.1016\/j.jbo.2019.100231_bib0071","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1038\/sj.leu.2404489","article-title":"Mesenchymal stem cells inhibit proliferation and apoptosis of tumor cells: impact on in vivo tumor growth","volume":"21","author":"Ramasamy","year":"2007","journal-title":"Leukemia"},{"key":"10.1016\/j.jbo.2019.100231_bib0072","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1038\/nature06188","article-title":"Mesenchymal stem cells within tumour stroma promote breast cancer metastasis","volume":"449","author":"Karnoub","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.jbo.2019.100231_bib0073","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1002\/jgm.840","article-title":"Human mesenchymal stem cells (hMSCs) expressing truncated soluble vascular endothelial growth factor receptor (tsFlk-1) following lentiviral-mediated gene transfer inhibit growth of Burkitt \u2019 s lymphoma in a murine model","volume":"8","author":"Kyriakou","year":"2006","journal-title":"J Gene Med"},{"key":"10.1016\/j.jbo.2019.100231_bib0074","doi-asserted-by":"crossref","first-page":"e89595","DOI":"10.1371\/journal.pone.0089595","article-title":"Human adipose tissue-derived stromal \/ stem cells promote migration and early metastasis of triple negative breast cancer xenografts","volume":"9","author":"Rowan","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.jbo.2019.100231_bib0075","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.5966\/sctm.2015-0300","article-title":"Opposite effects of coinjection and distant injection of mesenchymal stem cells on breast tumor cell growth","volume":"5","author":"Zheng","year":"2016","journal-title":"Stem. Cells. Transl. Med."},{"key":"10.1016\/j.jbo.2019.100231_bib0076","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1532\/IJH97.06230","article-title":"Mesenchymal stem cells in cancer: tumor-associated fibroblasts and cell-based delivery vehicles","volume":"86","author":"Hall","year":"2007","journal-title":"Int. J. Hematol"},{"key":"10.1016\/j.jbo.2019.100231_bib0077","first-page":"4","article-title":"Mesenchymal stem cell transition to tumor-associated fibroblasts contributes to fibrovascular network expansion and tumor progression","author":"Spaeth","year":"2009","journal-title":"PLoS One"},{"key":"10.1016\/j.jbo.2019.100231_bib0078","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1089\/ten.2005.11.1727","article-title":"Use of mesenchymal stem cells to facilitate bone regeneration in normal and chemotherapy-treated rats","volume":"11","author":"Lee","year":"2005","journal-title":"Tissue Eng"},{"key":"10.1016\/j.jbo.2019.100231_bib0079","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1089\/ten.2006.12.1617","article-title":"Do autologous mesenchymal stem cells augment bone growth and contact to massive bone tumor implants?","volume":"12","author":"Kalia","year":"2006","journal-title":"Tissue Eng"},{"key":"10.1016\/j.jbo.2019.100231_bib0080","doi-asserted-by":"crossref","DOI":"10.1097\/01.prs.0000479989.88114.8b","article-title":"Opposite effects of soluble factors secreted by adipose tissue on proliferating and quiescent osteosarcoma cells","author":"Avril","year":"2016","journal-title":"Plast. Reconstr. Surg"},{"key":"10.1016\/j.jbo.2019.100231_bib0081","doi-asserted-by":"crossref","DOI":"10.1111\/j.1349-7006.2010.01788.x","article-title":"Human mesenchymal stem cells promote growth of osteosarcoma: involvement of interleukin-6 in the interaction between human mesenchymal stem cells and Saos-2","author":"Bian","year":"2010","journal-title":"Cancer Sci"},{"key":"10.1016\/j.jbo.2019.100231_bib0082","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2012.06.006","article-title":"STAT3 activation by IL-6 from mesenchymal stem cells promotes the proliferation and metastasis of osteosarcoma","author":"Tu","year":"2012","journal-title":"Cancer Lett"},{"key":"10.1016\/j.jbo.2019.100231_sbref0085oo","first-page":"23809","article-title":"Adipose-derived mesenchymal stem cells promote osteosarcoma proliferation and metastasis by activating the STAT3 pathway","volume":"8","author":"Wang","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.jbo.2019.100231_bib0084","doi-asserted-by":"crossref","DOI":"10.1007\/s00264-014-2384-0","article-title":"Regenerative therapy with mesenchymal stem cells at the site of malignant primary bone tumour resection: what are the risks of early or late local recurrence?","author":"Hernigou","year":"2014","journal-title":"Int. Orthop"},{"key":"10.1016\/j.jbo.2019.100231_bib0085","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0010999","article-title":"Safety concern between autologous fat graft, mesenchymal stem cell and osteosarcoma recurrence","author":"Perrot","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.jbo.2019.100231_bib0086","doi-asserted-by":"crossref","DOI":"10.1007\/s11999-015-4362-2","article-title":"Do mesenchymal stromal cells influence microscopic residual or metastatic osteosarcoma in a murine model?","author":"Aanstoos","year":"2016","journal-title":"Clin. Orthop. Relat. Res"},{"key":"10.1016\/j.jbo.2019.100231_bib0087","article-title":"Mesenchymal stem cells promote tumor engraftment and metastatic colonization in rat osteosarcoma model","author":"Tsukamoto","year":"2012","journal-title":"Int. J. Oncol"},{"key":"10.1016\/j.jbo.2019.100231_bib0088","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.3892\/or.2015.3711","article-title":"Effect of local treatment with adipose tissue-derived mesenchymal stem cells in the early tumorigenesis of osteosarcoma","volume":"33","author":"Lee","year":"2015","journal-title":"Oncol. Rep"},{"key":"10.1016\/j.jbo.2019.100231_bib0089","doi-asserted-by":"crossref","DOI":"10.3892\/or.2013.2619","article-title":"CXCR4-mediated osteosarcoma growth and pulmonary metastasis is promoted by mesenchymal stem cells through VEGF","author":"Zhang","year":"2013","journal-title":"Oncol. Rep"},{"key":"10.1016\/j.jbo.2019.100231_bib0090","doi-asserted-by":"crossref","DOI":"10.1186\/s12957-015-0465-1","article-title":"Bone marrow mesenchymal stem cells promote osteosarcoma cell proliferation and invasion","author":"Yu","year":"2015","journal-title":"World J. Surg. Oncol"},{"key":"10.1016\/j.jbo.2019.100231_bib0091","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2015.10.018","article-title":"A novel antagonist of CXCR4 prevents bone marrow-derived mesenchymal stem cell-mediated osteosarcoma and hepatocellular carcinoma cell migration and invasion","author":"Fontanella","year":"2016","journal-title":"Cancer Lett"},{"key":"10.1016\/j.jbo.2019.100231_bib0092","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2009.02.022","article-title":"Human mesenchymal stem cells (hMSCs) target osteosarcoma and promote its growth and pulmonary metastasis","author":"Xu","year":"2009","journal-title":"Cancer Lett"},{"key":"10.1016\/j.jbo.2019.100231_bib0093","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbo.2015.11.002","article-title":"Mesenchymal stem cells increase proliferation but do not change quiescent state of osteosarcoma cells: potential implications according to the tumor resection status","author":"Avril","year":"2016","journal-title":"J. Bone Oncol."},{"key":"10.1016\/j.jbo.2019.100231_bib0094","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1007\/s11999-015-4362-2","article-title":"Do mesenchymal stromal cells influence microscopic residual or metastatic osteosarcoma in a murine model?","volume":"474","author":"Aanstoos","year":"2016","journal-title":"Clin. Orthop. Relat. Res"},{"key":"10.1016\/j.jbo.2019.100231_bib0095","first-page":"163","article-title":"Mesenchymal stem cells promote tumor engraftment and metastatic colonization in rat osteosarcoma model","volume":"40","author":"Tsukamoto","year":"2012","journal-title":"Int. J. Oncol"},{"key":"10.1016\/j.jbo.2019.100231_bib0096","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12957-015-0754-8","article-title":"Bone marrow mesenchymal stem cells promote osteosarcoma cell proliferation and invasion","volume":"13","author":"Yu","year":"2015","journal-title":"World J. Surg. Oncol"},{"key":"10.1016\/j.jbo.2019.100231_bib0097","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.jbo.2015.11.002","article-title":"Mesenchymal stem cells increase proliferation but do not change quiescent state of osteosarcoma cells: potential implications according to the tumor resection status, J","volume":"5","author":"Avril","year":"2016","journal-title":"Bone Oncol"},{"key":"10.1016\/j.jbo.2019.100231_bib0098","doi-asserted-by":"crossref","first-page":"2554","DOI":"10.1111\/j.1349-7006.2010.01731.x","article-title":"Human mesenchymal stem cells promote growth of osteosarcoma: involvement of interleukin-6 in the interaction between human mesenchymal stem cells and Saos-2","volume":"101","author":"Bian","year":"2010","journal-title":"Cancer Sci"},{"key":"10.1016\/j.jbo.2019.100231_bib0099","first-page":"7","article-title":"Mesenchymal stem cells promote osteosarcoma cell survival and drug resistance through activation of STAT3","author":"Tu","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.jbo.2019.100231_bib0100","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1007\/s00264-014-2384-0","article-title":"Regenerative therapy with mesenchymal stem cells at the site of malignant primary bone tumour resection: what are the risks of early or late local recurrence?","volume":"38","author":"Hernigou","year":"2014","journal-title":"Int. Orthop"},{"key":"10.1016\/j.jbo.2019.100231_bib0101","first-page":"5","article-title":"Safety concern between autologous fat graft, mesenchymal stem cell and osteosarcoma recurrence","author":"Perrot","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.jbo.2019.100231_bib0102","first-page":"3603","article-title":"Bone marrow-derived mesenchymal stem cells as vehicles for interferon-beta delivery into tumors","volume":"62","author":"Studeny","year":"2002","journal-title":"Cancer Res"},{"key":"10.1016\/j.jbo.2019.100231_bib0103","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.bbmt.2006.10.016","article-title":"Mesenchymal Stromal Cells","volume":"13","author":"Horwitz","year":"2007","journal-title":"Biol. Blood Marrow Transplant"},{"key":"10.1016\/j.jbo.2019.100231_bib0104","doi-asserted-by":"crossref","DOI":"10.1038\/bjc.2013.422","article-title":"Interferon-\u03b2 gene-modified human bone marrow mesenchymal stem cells attenuate hepatocellular carcinoma through inhibiting AKT\/FOXO3a pathway","author":"Xie","year":"2013","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.jbo.2019.100231_bib0105","first-page":"2853","article-title":"Antitumor therapeutic effects of cytosine deaminase and interferon-\u03b2 against endometrial cancer cells using genetically engineered stem cells in vitro","volume":"31","author":"Yi","year":"2011","journal-title":"Anticancer Res"},{"key":"10.1016\/j.jbo.2019.100231_bib0106","article-title":"Synergistic effect of therapeutic stem cells expressing cytosine deaminase and interferon-beta via apoptotic pathway in the metastatic mouse model of breast cancer","volume":"7","author":"Yi","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.jbo.2019.100231_bib0107","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.lungcan.2010.01.003","article-title":"Human umbilical cord matrix\u2013derived stem cells expressing interferon-\u03b2 gene significantly attenuate bronchioloalveolar carcinoma xenografts in SCID mice","volume":"70","author":"Matsuzuka","year":"2010","journal-title":"Lung Cancer"},{"key":"10.1016\/j.jbo.2019.100231_bib0108","doi-asserted-by":"crossref","DOI":"10.1016\/j.jcyt.2012.10.003","article-title":"Tumor stroma engraftment of gene-modified mesenchymal stem cells as anti-tumor therapy against ovarian cancer","author":"Dembinski","year":"2013","journal-title":"Cytotherapy"},{"key":"10.1016\/j.jbo.2019.100231_bib0109","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2015.10.031","article-title":"Interferon-\u03b12b gene-modified human bone marrow mesenchymal stem cells inhibit hepatocellular carcinoma by reducing the Notch1 levels","author":"Su","year":"2015","journal-title":"Life Sci"},{"key":"10.1016\/j.jbo.2019.100231_bib0110","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1002\/hon.779","article-title":"In vitro effect of adenovirus-mediated Human Gamma Interferon Gene Transfer into Human Mesenchymal Stem Cells for Chronic Myelogenous Leukemia","volume":"24","author":"Li","year":"2006","journal-title":"Hematol. Oncol"},{"key":"10.1016\/j.jbo.2019.100231_bib0111","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/318098","article-title":"IFN- \u03b3 -secreting-mesenchymal stem cells exert an antitumor effect in vivo via the trail pathway","author":"Yang","year":"2014","journal-title":"J. Immunol. Res"},{"key":"10.1016\/j.jbo.2019.100231_bib0112","doi-asserted-by":"crossref","DOI":"10.1016\/j.biocel.2012.04.015","article-title":"IFN-\u03b3-primed human bone marrow mesenchymal stem cells induce tumor cell apoptosis in vitro via tumor necrosis factor-related apoptosis-inducing ligand","author":"Du","year":"2012","journal-title":"Int. J. Biochem. Cell Biol"},{"key":"10.1016\/j.jbo.2019.100231_bib0113","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1038\/mt.2008.3","article-title":"A tumor-selective biotherapy with prolonged impact on established metastases based on cytokine gene-engineered MSCs","volume":"16","author":"Chen","year":"2008","journal-title":"Am. Soc. Gene Ther"},{"key":"10.1016\/j.jbo.2019.100231_bib0114","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1038\/gt.2010.170","article-title":"The effects of mesenchymal stem cells injected via different routes on modified IL-12-mediated antitumor activity","volume":"18","author":"Seo","year":"2011","journal-title":"Gene Ther"},{"key":"10.1016\/j.jbo.2019.100231_bib0115","doi-asserted-by":"crossref","first-page":"4810","DOI":"10.1158\/0008-5472.CAN-08-0160","article-title":"Neo-organoid of marrow mesenchymal stromal cells secreting interleukin-12 for breast cancer therapy","volume":"68","author":"Eliopoulos","year":"2008","journal-title":"Cancer Res"},{"key":"10.1016\/j.jbo.2019.100231_bib0116","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1038\/sj.gt.3302276","article-title":"Antitumor effect of genetically engineered mesenchymal stem cells in a rat glioma model","volume":"11","author":"Nakamura","year":"2004","journal-title":"Gene Ther"},{"key":"10.1016\/j.jbo.2019.100231_bib0117","doi-asserted-by":"crossref","DOI":"10.3892\/or.2015.4174","article-title":"Bone marrow-derived mesenchymal stem cells co-expressing interleukin-18 and interferon-\u03b2 exhibit potent antitumor effect against intracranial glioma in rats","author":"Xu","year":"2015","journal-title":"Oncol. Rep"},{"key":"10.1016\/j.jbo.2019.100231_bib0118","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1634\/stemcells.2006-0461","article-title":"Targeted delivery of CX3CL1 to multiple lung tumors by mesenchymal stem cells","volume":"25","author":"Xin","year":"2007","journal-title":"Stem Cells"},{"key":"10.1016\/j.jbo.2019.100231_bib0119","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1158\/1535-7163.MCT-05-0334","article-title":"Mesenchymal progenitor cells as cellular vehicles for delivery of oncolytic adenoviruses","volume":"5","author":"Komarova","year":"2006","journal-title":"MolCancer Ther"},{"key":"10.1016\/j.jbo.2019.100231_bib0120","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1111\/bph.12238","article-title":"Death receptors as targets","volume":"169","author":"Micheau","year":"2013","journal-title":"Br. J. Pharmacol"},{"key":"10.1016\/j.jbo.2019.100231_bib0121","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1002\/ijc.10376","article-title":"Chemotherapeutic agents sensitize osteogenic sarcoma cells, but not normal human bone cells, to APO2L \/ TRAIL-induced apoptosis","volume":"504","author":"Evdokiou","year":"2002","journal-title":"Int. J. Cancer."},{"key":"10.1016\/j.jbo.2019.100231_bib0122","doi-asserted-by":"crossref","first-page":"4134","DOI":"10.1158\/0008-5472.CAN-08-4698","article-title":"Mesenchymal stem cell delivery of TRAIL can eliminate metastatic cancer","volume":"69","author":"Loebinger","year":"2009","journal-title":"Cancer Res"},{"key":"10.1016\/j.jbo.2019.100231_bib0123","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/1074-7613(95)90057-8","article-title":"Identification and characterization of a new member of the TNF family that induces apoptosis","volume":"3","author":"Wiley","year":"1995","journal-title":"Immunity"},{"key":"10.1016\/j.jbo.2019.100231_bib0124","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1172\/JCI6926","article-title":"Safety and antitumor activity of recombinant soluble Apo2 ligand","volume":"104","author":"Ashkenazi","year":"1999","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.jbo.2019.100231_bib0125","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1634\/stemcells.2008-0831","article-title":"Tumor immunotherapy using gene-modified human mesenchymal stem cells loaded into synthetic extracellular matrix scaffolds","volume":"27","author":"Compte","year":"2009","journal-title":"Stem Cells"},{"key":"10.1016\/j.jbo.2019.100231_bib0126","doi-asserted-by":"crossref","unstructured":"Z. Gamie, K. Kapriniotis, D. Papanikolaou, E. Haagensen, R. Da, C. Ribeiro, K. Dalgarno, A. Krippner-Heidenreich, C. Gerrand, E. Tsiridis, K. Samora Rankin, TNF-related apoptosis-inducing ligand (TRAIL) for bone sarcoma treatment: pre-clinical and clinical data, (2017). doi:10.1016\/j.canlet.2017.08.036.","DOI":"10.1016\/j.canlet.2017.08.036"},{"key":"10.1016\/j.jbo.2019.100231_bib0127","first-page":"9","article-title":"MSC-delivered soluble TRAIL and paclitaxel as novel combinatory treatment for pancreatic adenocarcinoma","author":"Rossignoli","year":"2019","journal-title":"Theranostics"},{"key":"10.1016\/j.jbo.2019.100231_bib0128","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13045-016-0379-6","article-title":"Mesenchymal stromal cells as vehicles of for the treatment of B cell lymphoma combined with IDO pathway inhibitor D -1-methyl-tryptophan","volume":"56","author":"Zhang","year":"2017","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.jbo.2019.100231_bib0129","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1002\/jgm.1552","article-title":"Mesenchymal stem cells as vehicles for targeted delivery of anti-angiogenic protein to solid tumors","volume":"13","author":"Ghaedi","year":"2011","journal-title":"J. Gene Med."},{"key":"10.1016\/j.jbo.2019.100231_bib0130","doi-asserted-by":"crossref","unstructured":"Z. Karjoo, X. Chen, A. Hatefi, Progress and problems with the use of suicide genes for targeted cancer therapy,.Progress 2017. doi:10.1016\/j.addr.2015.05.009.","DOI":"10.1016\/j.addr.2015.05.009"},{"key":"10.1016\/j.jbo.2019.100231_bib0131","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1002\/jgm.1313","article-title":"Retroviral vector-producing mesenchymal stem cells for targeted suicide cancer gene therapy","volume":"11","author":"Uchibori","year":"2009","journal-title":"J. Gene Med."},{"key":"10.1016\/j.jbo.2019.100231_bib0132","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1002\/jgm.2826","article-title":"Targeted inhibition of osteosarcoma tumor growth by bone marrow-derived mesenchymal stem cells expressing cytosine ... Targeted inhibition of osteosarcoma tumor growth by bone marrow-derived mesenchymal stem cells expressing cytosine deaminase \/ 5- fl uor","volume":"17","author":"NguyenThai","year":"2015","journal-title":"J. Gene Med."},{"key":"10.1016\/j.jbo.2019.100231_bib0133","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1080\/14712598.2016.1196179","article-title":"Expert opinion on biological therapy harnessing mesenchymal stem cell homing as an anticancer therapy","volume":"16","author":"Hagenhoff","year":"2016","journal-title":"Expert Opin. Biol. Ther"},{"key":"10.1016\/j.jbo.2019.100231_bib0134","doi-asserted-by":"crossref","first-page":"6304","DOI":"10.1158\/0008-5472.CAN-06-4024","article-title":"Adipose tissue\u202f\u2212\u202fderived human mesenchymal stem cells mediated prodrug cancer gene therapy mediated prodrug cancer gene therapy","volume":"67","author":"Kucerova","year":"2007","journal-title":"Cancer Res."},{"key":"10.1016\/j.jbo.2019.100231_bib0135","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1002\/jgm.1239","article-title":"Cytosine deaminase expressing human mesenchymal stem cells mediated tumour regression in melanoma bearing mice","volume":"10","author":"Kucerova","year":"2008","journal-title":"J Gene Med"},{"key":"10.1016\/j.jbo.2019.100231_bib0136","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1089\/hum.2015.135","article-title":"Mesenchymal stem cells engineered to secrete pigment epithelium derived factor inhibit tumor metastasis and the formation of malignant ascites in a murine colorectal peritoneal carcinomatosis model Liping","volume":"27","author":"Yang","year":"2016","journal-title":"Hum. Gene Ther"},{"key":"10.1016\/j.jbo.2019.100231_bib0137","doi-asserted-by":"crossref","unstructured":"C. Zeng, S. Zhou, Mesenchymal stem cell-based NK4 gene therapy in nude mice bearing gastric cancer xenografts, (2014) 2449\u20132462.","DOI":"10.2147\/DDDT.S71466"},{"key":"10.1016\/j.jbo.2019.100231_bib0138","doi-asserted-by":"crossref","unstructured":"Q. Chen, P. Cheng, T.A.O. Yin, H. He, L.I. Yang, Y. Wei, X. Chen, Therapeutic potential of bone marrow-derived mesenchymal stem cells producing pigment epithelium-derived factor in lung carcinoma, (2012) 527\u2013534. doi:10.3892\/ijmm.2012.1015.","DOI":"10.3892\/ijmm.2012.1015"},{"key":"10.1016\/j.jbo.2019.100231_bib0139","first-page":"1","article-title":"Mesenchymal stem cell secretome and regenerative therapy after cancer","volume":"95","author":"Zimmerlin","year":"2014","journal-title":"Biochimie"},{"key":"10.1016\/j.jbo.2019.100231_bib0140","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1002\/stem.1903","article-title":"Mesenchymal progenitors expressing TRAIL induce apoptosis in sarcomas","author":"Grisendi","year":"2015","journal-title":"Stem Cells"},{"key":"10.1016\/j.jbo.2019.100231_bib0141","first-page":"2704","article-title":"Ewing's sarcoma family tumors are sensitive to tumor necrosis factor-related apoptosis-inducing ligand and express death receptor 4 and death receptor 5","volume":"61","author":"Mitsiades","year":"2001","journal-title":"CANCER Res"},{"key":"10.1016\/j.jbo.2019.100231_bib0142","doi-asserted-by":"crossref","DOI":"10.1038\/sj.cdd.4400836","article-title":"Sensitivity of ewing's sarcoma to TRAIL-induced apoptosis","author":"Kontny","year":"2001","journal-title":"Cell Death Differ"},{"key":"10.1016\/j.jbo.2019.100231_bib0143","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1002\/1097-0215(20001015)88:2<252::AID-IJC17>3.0.CO;2-U","article-title":"Apoptotic responsiveness of the Ewing\u2019s sarcoma family of tumours to tumour necrosis factor-related apoptosis-inducing ligand (TRAIL)","volume":"88","author":"Van Valen","year":"2000","journal-title":"Int. J. Cancer."},{"key":"10.1016\/j.jbo.2019.100231_bib0144","doi-asserted-by":"crossref","first-page":"2802","DOI":"10.1002\/ijc.30402","article-title":"TRAIL delivered by mesenchymal stromal\/stem cells counteracts tumor development in orthotopic Ewing sarcoma models","volume":"139","author":"Guiho","year":"2016","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.jbo.2019.100231_bib0145","doi-asserted-by":"crossref","DOI":"10.1016\/j.jcyt.2018.06.013","article-title":"In vitro and in vivo discrepancy in inducing apoptosis by mesenchymal stromal cells delivering membrane-bound tumor necrosis factor\u2013related apoptosis inducing ligand in osteosarcoma pre-clinical models","author":"Guiho","year":"2018","journal-title":"Cytotherapy"},{"key":"10.1016\/j.jbo.2019.100231_bib0146","doi-asserted-by":"crossref","DOI":"10.1016\/j.cytogfr.2004.06.004","article-title":"The molecular triad OPG\/RANK\/RANKL: involvement in the orchestration of pathophysiological bone remodeling","author":"Theoleyre","year":"2004","journal-title":"Cytokine Growth Factor Rev"},{"key":"10.1016\/j.jbo.2019.100231_bib0147","doi-asserted-by":"crossref","DOI":"10.1158\/0008-5472.CAN-06-4130","article-title":"Therapeutic relevance of osteoprotegerin gene therapy in osteosarcoma: blockade of the vicious cycle between tumor cell proliferation and bone resorption","author":"Lamoureux","year":"2007","journal-title":"Cancer Res."},{"key":"10.1016\/j.jbo.2019.100231_bib0148","doi-asserted-by":"crossref","DOI":"10.2147\/DDDT.S77116","article-title":"Human mesenchymal stem cells as delivery of osteoprotegerin gene: Homing and therapeutic effect for osteosarcoma","author":"Qiao","year":"2015","journal-title":"Drug Des. Devel. Ther."},{"key":"10.1016\/j.jbo.2019.100231_bib0149","doi-asserted-by":"crossref","DOI":"10.3892\/ijo.2012.1523","article-title":"Therapeutic potential of stem cells expressing suicide genes that selectively target human breast cancer cells: evidence that they exert tumoricidal effects via tumor tropism (review)","author":"Yi","year":"2012","journal-title":"Int. J. Oncol"},{"key":"10.1016\/j.jbo.2019.100231_bib0150","doi-asserted-by":"crossref","DOI":"10.1016\/S1535-6108(04)00116-3","article-title":"Embryonic endothelial progenitor cells armed with a suicide gene target hypoxic lung metastases after intravenous delivery","author":"Wei","year":"2004","journal-title":"Cancer Cell"},{"key":"10.1016\/j.jbo.2019.100231_bib0151","doi-asserted-by":"crossref","DOI":"10.1158\/0008-5472.CAN-06-4024","article-title":"Adipose tissue-derived human mesenchymal stem cells mediated prodrug cancer gene therapy","author":"Kucerova","year":"2007","journal-title":"Cancer Res"},{"key":"10.1016\/j.jbo.2019.100231_bib0152","first-page":"3462","article-title":"Aerosol gene therapy with PEI:IL-12 eradicates osteosarcoma lung metastases","volume":"9","author":"Jia","year":"2003","journal-title":"Clin. Cancer Res"},{"key":"10.1016\/j.jbo.2019.100231_bib0153","doi-asserted-by":"crossref","DOI":"10.1158\/1541-7786.MCR-05-0092","article-title":"Interleukin-12 Up-regulates fas expression in human osteosarcoma and ewing's sarcoma cells by enhancing its promoter activity","author":"Zhou","year":"2005","journal-title":"Mol. Cancer Res"},{"key":"10.1016\/j.jbo.2019.100231_bib0154","first-page":"4066","article-title":"Interleukin (IL)-12 and IL-12 Gene Transfer Up-Regulate Fas Expression in Human Osteosarcoma and Breast Cancer Cells","volume":"61","author":"Lafleur","year":"2001","journal-title":"CANCER Res"},{"key":"10.1016\/j.jbo.2019.100231_bib0155","doi-asserted-by":"crossref","DOI":"10.1038\/sj.cgt.7700968","article-title":"Intratumor murine interleukin-12 gene therapy suppressed the growth of local and distant Ewing's sarcoma","author":"Jia","year":"2006","journal-title":"Cancer Gene Ther"},{"key":"10.1016\/j.jbo.2019.100231_bib0156","doi-asserted-by":"crossref","DOI":"10.1002\/cncr.24013","article-title":"Murine bone marrow-derived mesenchymal stem cells as vehicles for interleukin-12 gene delivery into ewing sarcoma tumors","author":"Duan","year":"2009","journal-title":"Cancer"},{"key":"10.1016\/j.jbo.2019.100231_bib0157","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.stem.2009.02.001","article-title":"Mesenchymal stem cell homing: the devil is in the details","volume":"4","author":"Karp","year":"2009","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.jbo.2019.100231_bib0158","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1038\/clpt.2011.14","article-title":"Multidrug efflux pumps and cancer stem cells: insights into multidrug resistance and therapeutic development","volume":"89","author":"Moitra","year":"2011","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.jbo.2019.100231_bib0159","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.jconrel.2014.10.015","article-title":"Nano-engineered mesenchymal stem cells as targeted therapeutic carriers","volume":"196","author":"Sadhukha","year":"2014","journal-title":"J. Control. Release."},{"key":"10.1016\/j.jbo.2019.100231_bib0160","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1186\/1741-7015-11-139","article-title":"Tissue-derived mesenchymal stromal cells used as vehicles for anti-tumor therapy exert different in vivoeffects on migration capacity and tumor growth","volume":"11","author":"Belmar-Lopez","year":"2013","journal-title":"BMC Med."},{"key":"10.1016\/j.jbo.2019.100231_bib0161","first-page":"1","article-title":"Mesenchymal stem cells as delivery vehicle of porphyrin loaded nanoparticles: effective photoinduced in vitro killing of osteosarcoma","author":"Duchi","year":"2013","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jbo.2019.100231_bib0162","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1136\/postgradmedj-2013-132387","article-title":"Mesenchymal stem cells: mechanisms and role in bone regeneration","volume":"90","author":"Qin","year":"2014","journal-title":"Postgrad. Med. J"},{"key":"10.1016\/j.jbo.2019.100231_bib0163","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1016\/j.injury.2011.03.030","article-title":"Mesenchymal stem cells and bone regeneration: current status","volume":"42","author":"Jones","year":"2011","journal-title":"Injury"},{"key":"10.1016\/j.jbo.2019.100231_bib0164","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1517\/14712598.2014.945414","article-title":"Skeletal tissue engineering using mesenchymal or embryonic stem cells: clinical and experimental data","volume":"14","author":"Gamie","year":"2014","journal-title":"Expert Opin. Biol. Ther"},{"key":"10.1016\/j.jbo.2019.100231_bib0165","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1097\/SAP.0000000000000083","article-title":"Adipose-derived stem cells","volume":"75","author":"Toyserkani","year":"2015","journal-title":"Ann. Plast. Surg"},{"key":"10.1016\/j.jbo.2019.100231_bib0166","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1590\/1414-431X20132929","article-title":"Osteogenesis induced in goat bone marrow progenitor cells by recombinant adenovirus coexpressing bone morphogenetic protein 2 and basic fibroblast growth factor","volume":"46","author":"Xu","year":"2013","journal-title":"Braz J Med Biol Res"},{"key":"10.1016\/j.jbo.2019.100231_bib0167","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1089\/ten.teb.2013.0204","article-title":"The roles of bone morphogenetic proteins and their signaling in the osteogenesis of adipose-derived stem cells","volume":"20","author":"Zhang","year":"2014","journal-title":"Tissue Eng. Part B. Rev"},{"key":"10.1016\/j.jbo.2019.100231_bib0168","first-page":"17","article-title":"Exosome: A novel approach to stimulate bone regeneration through regulation of osteogenesis and angiogenesis","author":"Qin","year":"2016","journal-title":"Int. J. Mol. Sci"},{"key":"10.1016\/j.jbo.2019.100231_bib0169","article-title":"Adult human mesenchymal stem cell differentiation at the cell population and single-cell levels under alternating electric current","volume":"22","author":"Wechsler","year":"2015","journal-title":"Tissue Eng. Part C Methods"},{"key":"10.1016\/j.jbo.2019.100231_bib0170","doi-asserted-by":"crossref","first-page":"44130","DOI":"10.1038\/srep44130","article-title":"An innovative approach for enhancing bone defect healing using plga scaffolds seeded with extracorporeal-shock-wave-treated bone marrow mesenchymal stem cells (BMSCs)","volume":"7","author":"Chen","year":"2017","journal-title":"Sci. Rep"},{"key":"10.1016\/j.jbo.2019.100231_bib0171","first-page":"8","article-title":"Directing lineage specification of human mesenchymal stem cells by decoupling electrical stimulation and physical patterning on unmodified graphene","author":"Balikov","year":"2016","journal-title":"Nanoscale"},{"key":"10.1016\/j.jbo.2019.100231_bib0172","doi-asserted-by":"crossref","first-page":"7800","DOI":"10.1016\/j.biomaterials.2014.05.052","article-title":"Bone regeneration in a massive rat femur defect through endochondral ossification achieved with chondrogenically differentiated MSCs in a degradable scaffold","volume":"35","author":"Harada","year":"2014","journal-title":"Biomaterials"},{"key":"10.1016\/j.jbo.2019.100231_bib0173","first-page":"7109","article-title":"Osteoinductive peptide-functionalized nanofibers with highly ordered structure as biomimetic scaffolds for bone tissue engineering","volume":"10","author":"Gao","year":"2015","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.jbo.2019.100231_bib0174","doi-asserted-by":"crossref","first-page":"23803","DOI":"10.18632\/oncotarget.15866","article-title":"Adipose-derived mesenchymal stem cells promote osteosarcoma proliferation and metastasis by activating the STAT3 pathway","volume":"8","author":"Wang","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.jbo.2019.100231_bib0175","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0166500","article-title":"Tumor-activated mesenchymal stromal cells promote osteosarcoma stemness and migratory potential via IL-6 secretion","volume":"11","author":"Cortini","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.jbo.2019.100231_bib0176","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1007\/s10555-016-9635-z","article-title":"Tissue engineering and regenerative medicine in musculoskeletal oncology","volume":"35","author":"Holzapfel","year":"2016","journal-title":"Cancer Metastasis Rev"},{"key":"10.1016\/j.jbo.2019.100231_bib0177","first-page":"S47","article-title":"Stem cell therapy: Is there a future for reconstruction of large bone defects?","volume":"47","author":"Watanabe","year":"2016","journal-title":"Injury"},{"key":"10.1016\/j.jbo.2019.100231_bib0178","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1111\/j.1525-1594.2006.00190.x","article-title":"Tissue engineering approach to the treatment of bone tumors: three cases of cultured bone grafts derived from patients\u2019 mesenchymal stem cells","volume":"30","author":"Morishita","year":"2006","journal-title":"Artif. Organs"},{"key":"10.1016\/j.jbo.2019.100231_bib0179","doi-asserted-by":"crossref","first-page":"e2220","DOI":"10.1097\/MD.0000000000002220","article-title":"Scaffold-free three-dimensional graft from autologous adipose-derived stem cells for large bone defect reconstruction: clinical proof of concept","volume":"94","author":"Dufrane","year":"2015","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.jbo.2019.100231_bib0180","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0139566","article-title":"Human adipose-derived mesenchymal stem cells in cell therapy: safety and feasibility in different \u201chospital exemption\u201d clinical applications","volume":"10","author":"V\u00e9riter","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.jbo.2019.100231_bib0181","series-title":"Advances in Experimental Medicine and Biology","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1007\/978-3-319-04843-7_19","article-title":"Natural killer cells for osteosarcoma","author":"Tarek","year":"2014"},{"key":"10.1016\/j.jbo.2019.100231_bib0182","doi-asserted-by":"crossref","DOI":"10.2217\/imt.14.36","article-title":"Cellular immunotherapy strategies for Ewing sarcoma","author":"Rossig","year":"2014","journal-title":"Immunotherapy"},{"key":"10.1016\/j.jbo.2019.100231_bib0183","doi-asserted-by":"crossref","DOI":"10.1016\/j.jcyt.2017.03.001","article-title":"Comparison of human mesenchymal stromal cells from four neonatal tissues: amniotic membrane, chorionic membrane, placental decidua and umbilical cord","author":"Ara\u00fajo","year":"2017","journal-title":"Cytotherapy"},{"key":"10.1016\/j.jbo.2019.100231_bib0184","first-page":"8","article-title":"Comparison of the biological characteristics of mesenchymal stem cells derived from the human placenta and umbilical cord","author":"Wu","year":"2018","journal-title":"Sci. Rep"},{"key":"10.1016\/j.jbo.2019.100231_bib0185","first-page":"1","article-title":"Effects of in vitro endochondral priming and pre-vascularisation of human MSC cellular aggregates in vivo","author":"Freeman","year":"2015","journal-title":"Stem Cell Res. Ther"},{"key":"10.1016\/j.jbo.2019.100231_bib0186","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1517\/14712598.2015.1068755","article-title":"Bone and cartilage regeneration with the use of umbilical cord mesenchymal stem cells","volume":"15","author":"Klontzas","year":"2015","journal-title":"Expert Opin. Biol. Ther"},{"key":"10.1016\/j.jbo.2019.100231_bib0187","doi-asserted-by":"crossref","DOI":"10.1155\/2017\/8619385","article-title":"Osteogenic differentiation capacity of in vitro cultured human skeletal muscle for expedited bone tissue engineering","author":"Miao","year":"2017","journal-title":"Biomed Res. Int"},{"key":"10.1016\/j.jbo.2019.100231_bib0188","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1073\/pnas.1423008112","article-title":"MSCs derived from iPSCs with a modified protocol are tumor-tropic but have much less potential to promote tumors than bone marrow MSCs","volume":"112","author":"Zhao","year":"2015","journal-title":"Proc. Natl. Acad. Sci. U. S. A"},{"key":"10.1016\/j.jbo.2019.100231_bib0189","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.bone.2012.05.019","article-title":"Enhancement of tibial regeneration in a rat model by adipose-derived stromal cells in a PLGA scaffold","volume":"51","author":"Park","year":"2012","journal-title":"Bone"},{"key":"10.1016\/j.jbo.2019.100231_bib0190","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40659-015-0053-4","article-title":"Using mesenchymal stem cells as a therapy for bone regeneration and repairing","volume":"48","author":"Shao","year":"2015","journal-title":"Biol. Res"},{"key":"10.1016\/j.jbo.2019.100231_bib0191","doi-asserted-by":"crossref","DOI":"10.1088\/1758-5082\/2\/2\/022001","article-title":"Tissue engineering by self-assembly and bio-printing of living cells","author":"Jakab","year":"2010","journal-title":"Biofabrication"},{"key":"10.1016\/j.jbo.2019.100231_bib0192","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2017.10.005","article-title":"Organ-on-chip models of cancer metastasis for future personalized medicine: from chip to the patient","author":"Caballero","year":"2017","journal-title":"Biomaterials"},{"key":"10.1016\/j.jbo.2019.100231_bib0193","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1051\/sicotj\/2017003","article-title":"Upper extremity sarcoma: impact of current practice guidelines and controversies on reconstructive approaches","volume":"3","author":"Dobke","year":"2017","journal-title":"Sicot-J"},{"key":"10.1016\/j.jbo.2019.100231_bib0194","doi-asserted-by":"crossref","first-page":"3307","DOI":"10.1158\/0008-5472.CAN-04-1874","article-title":"Human bone marrow\u2013derived mesenchymal stem cells in the treatment of gliomas","volume":"65","author":"Nakamizo","year":"2005","journal-title":"Cancer Res"},{"key":"10.1016\/j.jbo.2019.100231_bib0195","doi-asserted-by":"crossref","DOI":"10.1038\/sj.bjc.6604508","article-title":"VEGF expression by mesenchymal stem cells contributes to angiogenesis in pancreatic carcinoma","author":"Beckermann","year":"2008","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.jbo.2019.100231_bib0196","doi-asserted-by":"crossref","DOI":"10.1016\/j.mvr.2009.06.010","article-title":"The EGFR inhibitor gefitinib suppresses recruitment of pericytes and bone marrow-derived perivascular cells into tumor vessels","author":"Iivanainen","year":"2009","journal-title":"Microvasc. Res"},{"key":"10.1016\/j.jbo.2019.100231_bib0197","doi-asserted-by":"crossref","DOI":"10.1016\/j.expneurol.2005.11.027","article-title":"Vascular endothelial growth factor A contributes to glioma-induced migration of human marrow stromal cells (hMSC)","author":"Schichor","year":"2006","journal-title":"Exp. Neurol"},{"key":"10.1016\/j.jbo.2019.100231_bib0198","doi-asserted-by":"crossref","DOI":"10.1002\/pros.21140","article-title":"Effects of transplantation of adipose tissue-derived stem cells on prostate tumor","author":"Lin","year":"2010","journal-title":"Prostate"},{"key":"10.1016\/j.jbo.2019.100231_bib0199","doi-asserted-by":"crossref","DOI":"10.1158\/1078-0432.CCR-11-1916","article-title":"Omental adipose tissue-derived stromal cells promote vascularization and growth of endometrial tumors","author":"Klopp","year":"2012","journal-title":"Clin. Cancer Res"},{"key":"10.1016\/j.jbo.2019.100231_bib0200","doi-asserted-by":"crossref","DOI":"10.1002\/stem.787","article-title":"Bone marrow-derived mesenchymal stromal cells are attracted by multiple myeloma cell-produced chemokine CCL25 and favor myeloma cell growth in vitro and in vivo","author":"Xu","year":"2012","journal-title":"Stem Cells"},{"key":"10.1016\/j.jbo.2019.100231_bib0201","doi-asserted-by":"crossref","DOI":"10.1016\/j.yexcr.2008.07.028","article-title":"The isolation of novel mesenchymal stromal cell chemotactic factors from the conditioned medium of tumor cells","author":"Lin","year":"2008","journal-title":"Exp. Cell Res"},{"key":"10.1016\/j.jbo.2019.100231_bib0202","doi-asserted-by":"crossref","DOI":"10.1158\/1078-0432.CCR-07-0731","article-title":"Monocyte chemotactic protein-1 secreted by primary breast tumors stimulates migration of mesenchymal stem cells","author":"Dwyer","year":"2007","journal-title":"Clin. Cancer Res"},{"key":"10.1016\/j.jbo.2019.100231_bib0203","doi-asserted-by":"crossref","DOI":"10.1634\/stemcells.2008-0141","article-title":"Urokinase plasminogen activator and urokinase plasminogen activator receptor mediate human stem cell tropism to malignant solid tumors","author":"Gutova","year":"2008","journal-title":"Stem Cells"},{"key":"10.1016\/j.jbo.2019.100231_bib0204","doi-asserted-by":"crossref","DOI":"10.1158\/0008-5472.CAN-10-1254","article-title":"Human bone marrow-derived mscs can home to orthotopic breast cancer tumors and promote bone metastasis","author":"Goldstein","year":"2010","journal-title":"Cancer Res"},{"key":"10.1016\/j.jbo.2019.100231_bib0205","doi-asserted-by":"crossref","DOI":"10.1007\/s11060-007-9332-4","article-title":"Malignant gliomas actively recruit bone marrow stromal cells by secreting angiogenic cytokines","author":"Birnbaum","year":"2007","journal-title":"J. Neurooncol."},{"key":"10.1016\/j.jbo.2019.100231_bib0206","doi-asserted-by":"crossref","DOI":"10.1042\/BJ20131119","article-title":"TIMP-1 modulates chemotaxis of human neural stem cells through CD63 and integrin signalling","author":"Lee","year":"2014","journal-title":"Biochem. J"},{"key":"10.1016\/j.jbo.2019.100231_bib0207","doi-asserted-by":"crossref","DOI":"10.2147\/DDDT.S77116","article-title":"Human mesenchymal stem cells as delivery of osteoprotegerin gene: homing and therapeutic effect for osteosarcoma","author":"Qiao","year":"2015","journal-title":"Drug Des. Devel. Ther"}],"container-title":["Journal of Bone Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S221213741930017X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S221213741930017X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T20:18:30Z","timestamp":1761941910000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S221213741930017X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6]]},"references-count":207,"alternative-id":["S221213741930017X"],"URL":"https:\/\/doi.org\/10.1016\/j.jbo.2019.100231","relation":{},"ISSN":["2212-1374"],"issn-type":[{"value":"2212-1374","type":"print"}],"subject":[],"published":{"date-parts":[[2019,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mesenchymal stromal cells for bone sarcoma treatment: Roadmap to clinical practice","name":"articletitle","label":"Article Title"},{"value":"Journal of Bone Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jbo.2019.100231","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 The Authors. Published by Elsevier GmbH.","name":"copyright","label":"Copyright"}],"article-number":"100231"}}